Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 2 Effect of CRME on blood glucose level

From: Promising anitidiabetic potential of Cuscuta reflexa leaves methanol extract in alloxan-induced diabetic rats

Groups

Blood glucose level in mg/dL

Day 0

Day 9

Day 18

Day 27

Day 36

Day 45

Group I

80.4 ± 2.3

81.0 ± 2.4

79.2 ± 3.4

85.8 ± 4.5

88.6 ± 3.4

81.2 ± 4.3

Group II

237.9 ± 7.6a**

245.2 ± 8.9a**

251.7 ± 8.1a**

248.8 ± 7.5a**

253.4 ± 8.3a**

249.7 ± 7.3a**

Group III

258.4 ± 8.4a**

209.7 ± 8.1b*

162.9 ± 8.5b**

138.5 ± 6.9b**

125.7 ± 7.4b**

105.7 ± 5.4b**

Group IV

244.1 ± 9.2a**

227.2 ± 9.7bη

215.7 ± 7.6b*

190.8 ± 8.2b**

165.1 ± 7.8b**

137.1 ± 5.8b**

Group V

267.2 ± 10.4a**

215.8 ± 9.9bη

193.9 ± 9.1b**

166.3 ± 6.7b**

145.9 ± 6.5b**

125.9 ± 6.5b**

Group VI

245.5 ± 9.5a**

198.8 ± 10.1b**

175.1 ± 8.9b**

140.6 ± 7.8b**

133.5 ± 6.4b**

109.5 ± 5.4b**

  1. All values were expressed as mean ± S.E.M (n = 6). (*) designates statistically significant difference from the respective group (**p < 0.01) whereas (η) designates statistically no significant difference from the relevant group (p > 0.05) using ANOVA, followed by Dunnett’s multiple comparison test. a = while compared with healthy control, b = while compared with diabetic control. Group I = Healthy control, Group II = Diabetic control, Group III = Diabetic control + 10 mg/kg of gliclazide, Group IV = Diabetic control + 100 mg/kg CRME, Group V = Diabetic control + 200 mg/kg CRME, Group VI = Diabetic control + 400 mg/kg CRME